Scholars@Duke publication: Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis

Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis

Publication , Conference

Rudick, RA; Cookfair, RD; Ransohoff, R; Jacobs, L; Herndon, R; Richert, J; Salazar, A; Fischer, J; Granger, C; Simon, J; Goodkin, D

Published in: ANNALS OF NEUROLOGY

1996

ANNALS OF NEUROLOGY

0364-5134

1996

M104 / M104

APA

Chicago

ICMJE

MLA

NLM

Rudick, R. A., Cookfair, R. D., Ransohoff, R., Jacobs, L., Herndon, R., Richert, J., … Goodkin, D. (1996). Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis. In ANNALS OF NEUROLOGY (Vol. 40, pp. M104–M104).

Rudick, R. A., R. D. Cookfair, R. Ransohoff, L. Jacobs, R. Herndon, J. Richert, A. Salazar, et al. “Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis.” In ANNALS OF NEUROLOGY, 40:M104–M104, 1996.

Rudick RA, Cookfair RD, Ransohoff R, Jacobs L, Herndon R, Richert J, et al. Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis. In: ANNALS OF NEUROLOGY. 1996. p. M104–M104.

Rudick RA, Cookfair RD, Ransohoff R, Jacobs L, Herndon R, Richert J, Salazar A, Fischer J, Granger C, Simon J, Goodkin D. Cerebrospinal fluid abnormalities in a phase III trial interferon beta-1a (Avonex) for relapsing multiple sclerosis. ANNALS OF NEUROLOGY. 1996. p. M104–M104.

ANNALS OF NEUROLOGY

0364-5134

1996

M104 / M104